Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-06

Clinical Trial Update: Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Septic Shock [NA]

View source ↗

Summary

Clinical trial update on the safety and efficacy of Polymyxin B hemoperfusion for septic shock, with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polymyxin B hemoperfusion (Polymyxin B)

Snippet

Sponsor: Spectral Diagnostics (US) Inc. | Conditions: Septic Shock, Endotoxemia | NA | Status: COMPLETED | Results posted: 2019-02-06